| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.21 | 0.5 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.5 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.093 | 0.5 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |